https://www.selleckchem.com/pr....oducts/pexidartinib-
To describe the clinical, therapeutic and prognostic features of ductal carcinomas of the parotid gland. Five patients with ductal carcinoma of the parotid gland (primary and secondary carcinoma) treated, between 2007 and 2019, in our ENT department, were reviewed. Four men and one woman were included. The mean age was 61,4 years. One patient had a history of an invasive ductal carcinoma of the breast. Four patients consulted for swelling in the parotid region. One patient referred to our department for dysfunction of facia